Navigation Links
Somanetics Corporation to Present at Rodman & Renshaw Annual Global Investment Conference
Date:11/3/2008

- Somanetics to Webcast Presentation on November 10, 2008 at 4:30 P.M. ET -

TROY, Mich., Nov. 3 /PRNewswire-FirstCall/ -- Somanetics Corporation (Nasdaq: SMTS) today announced it will present at the Rodman & Renshaw Annual Global Investment Conference at the New York Palace Hotel in New York. William Iacona, Somanetics' chief financial officer, will make a 25-minute presentation on Monday, November 10, 2008 at 4:30 p.m. ET. The presentation will be webcast live. The webcast may be accessed by visiting the Investor Center section of Somanetics' website at http://www.somanetics.com . The presentation also will be archived on Somanetics' website for 30 days following the conference.

About Somanetics

Somanetics Corporation (Nasdaq: SMTS) develops, manufactures and markets the INVOS(R) Cerebral/Somatic Oximeter, a non-invasive patient monitoring system that continuously measures changes in the blood oxygen levels in the brain and elsewhere in the body in patients with or at risk for restricted blood flow. Surgeons, anesthesiologists and other medical professionals can use the information provided by the INVOS System, in conjunction with other available information, to identify oxygen imbalances in tissues beneath the sensor and take necessary corrective action, potentially improving patient outcomes and reducing the costs of care. The INVOS System has a nearly 11-year market track record supported by more than 600 clinical references, and is used at nea
'/>"/>

SOURCE Somanetics Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Somanetics Announces Share Repurchase Program Increased By $15 Million
2. Somanetics Receives 510(k) Clearance From the FDA to Expand INVOS System Labeling
3. Somanetics Corporation to Present at Citigroup 2008 Healthcare Conference
4. Somanetics Announces Share Repurchase Program Increased by $15 Million
5. Somanetics Announces Share Repurchase Program
6. Somanetics Reports Financial Results for the First Quarter of Fiscal 2008
7. Somanetics Corporation to Release First Quarter 2008 Financial Results and Host Conference Call March 18, 2008
8. Somanetics Corporation to Release Fourth Quarter and Fiscal 2007 Financial Results and Host Conference Call January 23, 2008
9. Somanetics Corporation to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
10. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
11. STERIS Corporation Announces Webcast of Analyst Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/20/2013)... MO (PRWEB) December 20, 2013 The ... for women using the contraceptive NuvaRing. Court records for ... caused blood clot-related injuries has risen*. , DrugRisk is ... By sharing the latest product recalls, safety alerts, research ... if others are experiencing similar side effects and decide ...
(Date:12/20/2013)... MillionaireCasket.com, a famous online supplier of various kinds of ... poplar wood caskets. What’s more, the company has started ... are as much as 40%. , There are thousands ... market for its excellent products and considerate service. The ... provide worldwide consumers with the best advice they need ...
(Date:12/19/2013)... 20, 2013 Reduce bags, dark circles, ... new Face Whisperer® Advanced Eye Gel . , ... Beauty®, and it now joins the popular Face ... three patented and tested ingredients that really work on ... "This is an advanced, highly performing serum to reduce ...
(Date:12/19/2013)... Autism Speaks, the world’s leading autism and science ... than $350,000 to 66 local organizations with the launch ... possible through Autism Speaks’ partnership with Sprouts Farmers ... natural foods retailers in the country. Service providers located ... eligible to apply: Arizona, California, Colorado, Oklahoma, Nevada, New ...
(Date:12/19/2013)... Ticket Down announces that they have slashed ticket prices ... first album "Pure Heroine." The world of music saw several ... stars was Lorde, who is the owner of the massive hit ... superstar of the year and it would be difficult to find ... is still in her teens and will be headlining her very ...
Breaking Medicine News(10 mins):Health News:New to DrugRisk: December Court Records Show Rise in NuvaRing Lawsuits 2Health News:MillionaireCasket.com’s Great Discounts On Solid Poplar Wood Caskets 2Health News:New Face Whisperer® Advanced Eye Gel Delivers Patented Ingredients to Reduce Dark Circles, Bags and Wrinkles; On Sale Now at Sublime Beauty® 2Health News:Autism Speaks Awards 66 Local Service Providers with Its Neighborhood Grants 2Health News:Autism Speaks Awards 66 Local Service Providers with Its Neighborhood Grants 3Health News:Lorde Tickets: Ticket Down Has Slashed Ticket Prices on all 2014 Lorde "Pure Heroine" Tour Dates 2Health News:Lorde Tickets: Ticket Down Has Slashed Ticket Prices on all 2014 Lorde "Pure Heroine" Tour Dates 3
... a Helping Hand, WEST PALM BEACH, Fla., May ... West Palm Beach home of,the American Lung Association of ... and Quantum Foundation to partner on one of,Palm Beach ... a 6000 square foot renovation by ALAFSE using,Leadership in ...
... is female issue, though almost half, infertility cases due to male factors ... ... factors, PURCHASE, N.Y., May 30 Among couples who ... an informal web survey conducted by IntegraMed, the leading operator of,fertility centers ...
... BOSTON, May 30 On June 5th at ... shareholders will vote for the,second year on a ... Compensation., The resolution received 42% last year., ... firm focused on,integrating environmental, social and governance factors ...
... in many homes whole milk is just as effective, ... (0.1%) barium suspension that is also commonly used as an oral ... a new study finds. , The study included 215 patients undergoing ... of the study. All patients were given an IV contrast media; ...
... A team of researchers, led by Dr Nicola Wiles ... the Peninsula Medical School in the South West, has ... Health Research Health Technology Assessment (NIHR HTA) programme for ... behavioural therapy (CBT) for patients with depression who do ...
... is available in German . , Viruses ... of an infected organism. This trait is now being exploited ... cells of a patient to treat genetic diseases or genetic ... described in the journal Angewandte Chemie, they have been able ...
Cached Medicine News:Health News:2701 Australian: A Unique Partnership 2Health News:2701 Australian: A Unique Partnership 3Health News:Fertility Specialists Decry Men's Reluctance to Seek Infertility Treatment 2Health News:Fertility Specialists Decry Men's Reluctance to Seek Infertility Treatment 3Health News:£1.2M trial to test effectiveness of cognitive behavioral therapy 2Health News:Self-assembled viruses 2
(Date:12/19/2013)... Dec. 19, 2013 Decision Resources, one ... for pharmaceutical and healthcare issues, finds that the ... diseases market (incorporating pharmacotherapies for the treatment of ... stroke and transient ischemic attack) will drive the ... to $47 billion in 2022. The launch of ...
(Date:12/19/2013)... MALVERN, Pa. and MONTREAL ... (NASDAQ: ENDP ) ("Endo") today announced that ... of 1976, as amended ("HSR Act") in connection with ... ("Paladin Labs") was terminated by the United States Federal ... announced that the Canadian Competition Bureau issued a no-action ...
(Date:12/19/2013)... 19, 2013  ViaCyte, Inc., a leading regenerative ... treatment of diabetes, announced today that Mark ... Board of Directors. (Logo: http://photos.prnewswire.com/prnh/20121026/LA00871LOGO-a ... seasoned financial executive with over 30 years of ... president and Chief Financial Officer at Amylin Pharmaceuticals, ...
Breaking Medicine Technology:The Atherothrombotic Diseases Market Will Increase from $36 Billion in 2012 to $47 Billion in 2022 2Endo Announces Early Termination of HSR Act Waiting Period and Canadian Competition Act Compliance in Connection with Its Proposed Acquisition of Paladin Labs 2Endo Announces Early Termination of HSR Act Waiting Period and Canadian Competition Act Compliance in Connection with Its Proposed Acquisition of Paladin Labs 3Endo Announces Early Termination of HSR Act Waiting Period and Canadian Competition Act Compliance in Connection with Its Proposed Acquisition of Paladin Labs 4Endo Announces Early Termination of HSR Act Waiting Period and Canadian Competition Act Compliance in Connection with Its Proposed Acquisition of Paladin Labs 5ViaCyte Appoints Mark Foletta, former CFO of Amylin, to its Board of Directors 2ViaCyte Appoints Mark Foletta, former CFO of Amylin, to its Board of Directors 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: